Skip to main content
SpringerLink
Log in
Book cover

Intragastric Balloon for Weight Management pp 219–227Cite as

Drug Regimen and Intragastric Balloon: Pre, Post, During, Combined

  • Chapter
  • First Online:

  • 270 Accesses

Abstract

Lifestyle modification continues to be the basis of obesity treatment despite the lack of substantial long-term efficacy. Pharmacotherapy is an important viable treatment option for many patients who do not respond to lifestyle therapy and who are not candidates for bariatric surgery. When associated with the intragastric balloon treatment, pharmacotherapy can be an excellent tool for optimizing results.

In this chapter, we will address the current antiobesity drugs that can be used concomitantly with the intragastric balloon, as well as the symptomatic drugs used to reduce the common adverse effects of this procedure, and pharmacologic strategies for risk reduction and complications of the method.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ladenheim EE. Liraglutide and obesity: a review of the data so far. Drug Des Devel Ther. 2015;9:1867–75.

    Article  CAS  Google Scholar 

  2. Almeida N, et al. O balão intragástrico nas formas graves de obesidade. GE J Port Gastrenterol. 2006;13:220–5.

    Google Scholar 

  3. Neto MG, et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis. 2018;14:151–61.

    Article  Google Scholar 

  4. Coutinho WF, Cabral MD. A farmacoterapia da obesidade nos consensos. Arq Bras Endocrinol Metab, São Paulo. 2000;44(1):91–4.

    Article  Google Scholar 

  5. Onge E, Miller S, Motycka C. Liraglutide (Saxenda®) as a treatment for obesity. Food Nutr Sci. 2016;7:227–35.

    Google Scholar 

  6. Christou GA, Katsiki N, Kiortsis DN. The current role of Liraglutide in the pharmacotherapy of obesity. Curr Vasc Pharmacol. 2016;14(2):201–7.

    Article  CAS  Google Scholar 

  7. Nissen LP, et al. Intervenções para tratamento da obesidade: revisão sistemática. Rev. Bras. Med. Farm. Comunidade, Florianópolis-SC, Brasil. 2012;7(24):184–90.

    Article  Google Scholar 

  8. Paumgartten FJR. Tratamento farmacológico da Obesidade: a perspectiva da saúde pública. Cad Saúde Pública, Rio de Janeiro. 2011;27(3):404–5.

    Article  Google Scholar 

  9. Camilleri M. Combining therapies to personalize and optimize treatment. Washington, D.C.: DDW; 2018.

    Google Scholar 

  10. Machado ACC, et al. Avaliação da associação da terapêutica medicamentosa e a terapia cognitivo comportamental no tratamento da obesidade. Rev Bras Med. 2002;59(1/2):47–53.

    Google Scholar 

  11. Halpern A, Mancini MC. O tratamento da obesidade no paciente portador de hipertensão arterial. Revista Brasileira de Hipertensão. 2000;7(2):166–71.

    Google Scholar 

  12. DO Prado CN, et al. Phytotherapic use in the treatment of obesity/O uso de fitoterapicos no tratamento da obesidade. Revista Brasileira de Obesidade, Nutrição e Emagrecimento. 2010;4(19):14. Academic OneFile, Accessed 28 Feb 2018.

    Google Scholar 

  13. Verrengia EC, Kinoshita SAT, Amadei JL. Medicamentos Fitoterápicos no Tratamento da Obesidade. UNICIÊNCIAS. 2013;17:53–8.

    Google Scholar 

  14. DISBIOSE e Obesidade. Conexões e Curiosidades: Hábitos Saudáveis. Essential Nutrition, ed.10. 2017.

    Google Scholar 

  15. Boof RM. Efeito de uma intervenção interdisciplinar baseada no modelo transteórico de mudança de comportamento em adolescentes comsobrepeso ou obesidade. 110f. Tese (Doutorado em Psicologia) – PUCRS: Paraná; 2017.

    Google Scholar 

  16. Mazure RA, et al. Adherencia y fidelidad en el paciente tratado con balón intragástrico. Nutr Hosp Madrid. 2014;29(1):50–6.

    CAS  Google Scholar 

  17. Halpern A, et al. Experiência clínica com o uso conjunto de sibutramina e orlistat em pacientes obesos, vol 44(1). Arq Bras Endocrinol Metab: São Paulo; 2000. p. 103–5.

    Google Scholar 

  18. Heidi L. Slim spoils for obesity drugs: drug makers struggle to find viable treatments for global epidemic. Nature. 2010;468:878.

    Google Scholar 

  19. Quintas S. Análise de uma amostra de indivíduos após remoção do balão intragástrico e do seu acompanhamento nutricional. Porto: FCNAUP; 2009.

    Google Scholar 

  20. Conte SC, De Campos SB. Perspectivas de perda de peso com uso de liraglutida: revisão da literatura. BJSCR. 2014–2015;9(1):84–90.

    Google Scholar 

  21. Pajecki D, et al. Tratamento de curto prazo com liraglutide no reganho de peso após cirurgia bariátrica. Rev Col Bras Cir. 2012;40(3):191–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bariatric Endoscopy and Gastroenterology, Endovitta Institute, São Paulo, SP, Brazil

    Elaine Moreira

  2. Department of Surgery and Physiology, Gastros Bahia, Feira de Santana, BA, Brazil

    Antonio Fábio Teixeira

Authors
  1. Elaine Moreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Fábio Teixeira
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department Digestive Surgery, ABC Faculty of Medicine, São Paulo, São Paulo, Brazil

    Manoel Galvao Neto

  2. Department of Surgery, Federal University of Pernambuco, Recife, Pernambuco, Brazil

    Lyz Bezerra Silva

  3. Department of Gastroenterology and Bariatric Endoscopy, Gástrica Clinic, Florianópolis, Santa Catarina, Brazil

    Eduardo N. Usuy Jr.

  4. Department of Surgery, Federal University of Pernambuco, Recife, Pernambuco, Brazil

    Josemberg M. Campos

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Moreira, E., Teixeira, A.F. (2020). Drug Regimen and Intragastric Balloon: Pre, Post, During, Combined. In: Galvao Neto, M., Silva, L., Usuy Jr., E., Campos, J. (eds) Intragastric Balloon for Weight Management. Springer, Cham. https://doi.org/10.1007/978-3-030-27897-7_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27897-7_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27896-0

  • Online ISBN: 978-3-030-27897-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation